ARNA Financial Facts

Total interest and other expense, net: 32.85M
Net loss: 7.48M
See Full Income Statement

Accounts receivable: 7.35M
Total current liabilities: 61.3M
See Full Balance Sheet

Arena Pharmaceuticals, Inc. (ARNA) Earnings

  |   Expand Research on ARNA
Next EPS Date 11/7/14 *Est. EPS Growth Rate -83.3% *Last Qtr.
Average EPS % Beat Rate +35.2% Revenue Growth Rate -81.4% *Last Qtr.
Average % Move 1-Wk after EPS +3.3% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/4/13 Q412 -$0.10-$0.03 -$0.07$1.94M$21.94M N/A Details
5/10/11 Q111 -$0.35-$0.21 -$0.14$3.92M$3.29M N/A Details
8/9/12 Q212 -$0.12-$0.08 -$0.04$22M$7.38M N/A Details
11/9/10 Q310 -$0.31-$0.23 -$0.08N/AN/A N/A Details
5/12/14 Q114 -$0.12-$0.10 -$0.02$6.8M$7.98M N/A Details
5/2/13 Q113 $0.09$0.11 -$0.02N/A$50.36M N/A Details
11/9/11 Q311 -$0.16-$0.14 -$0.02$3.46M$3.37M N/A Details
3/11/11 Q410 -$0.23-$0.21 -$0.02$4.01M$4.81M N/A Details